The Medically Engineered Solutions in Healthcare (MESH) Incubator: A case study of innovation “push”

Doctor showing a patient information on a touchscreen device

In an opinion piece for STAT, Marc Succi, MD, Clinician-in-Residence at Mass General Brigham Innovation, addresses the importance of innovation education and support for all health care professionals.  Read more about the Medically Engineered Solutions in Healthcare (MESH) Incubator established at Mass General Brigham  in 2016, and how we are working to change the landscape…

Read More

2022 World Medical Innovation Forum | Day 3 Recap

WMIF 2022 Recap

The final day of the World Medical Innovation Forum began with a discussion on the fast-moving landscape of cell therapies for cancer.   The Cell Therapy Landscape | CAR-T to Stem Cells Christina Coughlin, MD, PhD, CEO of CytoImmune, detailed three biological principles her team is factoring into their approach to developing T cell and…

Read More

2022 World Medical Innovation Forum | Day 2 Recap

WMIF 2022 Recap

Day 2 of World Medical Innovation Forum kicked off with a fireside chat with FDA commissioner Robert Califf, MD.   Califf, who recently began his second tour as commissioner, was asked about accelerated approval for new drugs with unvalidated biomarkers based on the opinion it is “reasonably likely” a change in these biomarkers predicts a…

Read More

2022 World Medical Innovation Forum | Day 1 Recap

WMIF 2022 Recap

The 2022 World Medical Innovation Forum returned as an in-person event with a partnership between Mass General Brigham and Bank of America. Now in its eighth year, the Forum provides an unprecedented three-day immersion into the world of gene and cell therapies (GCT) and the investment opportunities emerging from this astonishing field. First Look Sessions…

Read More

Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham

Disruptive Dozen

Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and autoimmune diseases BOSTON, MA – May 4, 2022 — Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in…

Read More

Mass General Brigham Awards $1 Million to Biotech Breakthroughs

Partners FORUM 2022 GRAPHICS Social Media 220501 1352 150 IDG PR

Game-changing biotech innovations include new delivery system for brain cancer therapeutics, better detection of potential pregnancy complications, single-handed central line placement device, and more. BOSTON, MA – May 3, 2022 Ten biotech advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2022 round of awards for the highly competitive grant…

Read More